Acg Pharma Technologies Private Limited - Company Profile

It is a machinery and equipment private limited company based in Mumbai, Maharashtra, India, established in 1996.
1996 Mumbai, Maharashtra, India Amalgamated
Last Updated:
About Acg Pharma Technologies Private Limited

Acg Pharma Technologies Private Limited, a amalgamated private limited company, was established on 17 December 1996 in Mumbai, Maharashtra, India. Engaging in process machinery & industrial equipment within the manufacturing sector, it holds CIN: U29251MH1996PTC104558. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹126.20 Cr and a paid-up capital of ₹122.29 Cr.

Formerly known as Pam-Glatt Pharma Technologies Limited, Pam-Glatt Pharma Technologies Private Limited. It upholds a compliant status. Employing 348 professional, Its leadership includes Karan Jasjit Singh (Director), Jasjit Daljit Singh (Director), Shaju Kunjuvareed Thommana (Whole-Time Director). Past directors included Sanjeev Kumar Dhiman, Shirish Dhande, Karan Jasjit Singh. It holds no open charges and ₹2.63 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 1001 Dalamal House 10Th Floornariman Po, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U29251MH1996PTC104558

  • Registration Number

    104558

  • Incorporation Date

    17 December 1996

  • Authorized Capital

    ₹126.20 Cr

  • Paid-Up Capital

    ₹122.29 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 126.20 Cr
  • Paid Up Capital ₹ 122.29 Cr
  • Company Age 29 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 2.63 Cr
  • Revenue Growth **** -28.02%
  • Profit Growth **** -1145.41%
  • Ebitda **** -1448.53%
  • Net Worth -19.44%
  • Total Assets -12.86%
Company report

Acg Pharma Technologies Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Acg Pharma Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Acg Pharma Technologies Private Limited?
Current Directors
Name Designation Appointment Date Status
Karan Jasjit Singh Director 01 Apr 2013 Current
Jasjit Daljit Singh Director 17 Dec 1996 Current
Shaju Kunjuvareed Thommana Whole-Time Director 16 Oct 2019 Current
Ajit Daljit Singh Director 17 Dec 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 25 Jul 2019 Past
Pramod Abcsdd Whole-Time Director 09 Jan 2018 Past
Pramod Abcsdd Additional Director 30 Oct 2013 Past
Pramod Abcsdd Director 11 Jul 2018 Past
Pramod Abcsdd Director 30 Oct 2019 Past
Pramod Abcsdd Director 16 Jan 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acg Pharma Technologies.

Acg Pharma Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.02% decrease. The company also saw a substantial fall in profitability, with a 1145.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.44%.

Acg Pharma Technologies revenue growth over time
Acg Pharma Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-28.02%
*******
*******
*******
*******
Revenue from Operations
*******
-28.31%
*******
*******
*******
*******
Total Assets
*******
-12.86%
*******
*******
*******
*******
Profit or Loss
*******
-1145.41%
*******
*******
*******
*******
Net Worth
*******
-19.44%
*******
*******
*******
*******
EBITDA
*******
-1448.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acg Pharma Technologies?

In 2023, Acg Pharma Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹26,250,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 2.50 Cr
  • State Bank Of India : 0.13 Cr
Latest Charge Details
Date Lender Amount Status
09 Mar 2007 Axis Bank Limited ₹2.50 Cr Satisfied
14 Aug 2000 State Bank Of India ₹1.25 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Acg Pharma Technologies?

Acg Pharma Technologies has a workforce of 348 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acg Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acg Pharma Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acg Pharma Technologies
Recent Activity within the Organization
  • Annual General Meeting

    Acg Pharma Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Acg Pharma Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Shaju Kunjuvareed Thommana was appointed as a Whole-time director was appointed as a Whole-time director on 16 Oct 2019 & has been associated with this company since 6 years 7 months . was documented.

  • Director Appointment

    Progress on Rashmi Mishra was appointed as a Company Secretary was appointed as a Company Secretary on 25 Jul 2019 & has been associated with this company since 6 years 9 months . was documented.

  • Charges

    Progress on A charge registered on 09 Mar 2007 via Charge ID 10114672 with Axis Bank Limited was fully satisfied on 02 Jul 2015. was documented.

  • Director Appointment

    Karan Jasjit Singh was appointed as a Director was appointed as a Director on 01 Apr 2013 & has been associated with this company since 13 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement
Frequently Asked Questions
What is the CIN of Acg Pharma Technologies Private Limited?

The CIN of Acg Pharma Technologies Private Limited is U29251MH1996PTC104558.

Where is Acg Pharma Technologies Private Limited headquartered?

Acg Pharma Technologies Private Limited is headquartered at 1001 Dalamal House 10Th Floornariman Po, Mumbai, Maharashtra, 400021.

When was Acg Pharma Technologies Private Limited incorporated?

Acg Pharma Technologies Private Limited was incorporated on 17 December 1996.

Who are the current directors of Acg Pharma Technologies Private Limited?

The current directors of Acg Pharma Technologies Private Limited are

What is the primary industry of Acg Pharma Technologies Private Limited?

The primary industry of Acg Pharma Technologies Private Limited is Manufacturing.

Is Acg Pharma Technologies Private Limited a listed company?

Acg Pharma Technologies Private Limited is unlisted.

What is the capital structure of Acg Pharma Technologies Private Limited?

The authorized capital of Acg Pharma Technologies Private Limited is ₹126.20 Cr, and the paid-up capital is ₹122.29 Cr.

What is the compliance status of Acg Pharma Technologies Private Limited?

The compliance status of Acg Pharma Technologies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available